Editorial
Advanced Therapy for Intermediate-Risk Pulmonary Embolism
New England Journal of Medicine · 28.05.2026 · 394 (20) · 2052-2054
DOI: 10.1056/nejme2603115 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 28.05.2026. Verfasst von Alex C Spyropoulos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY.
- Feinstein Institutes for Medical Research, Manhasset, NY.
- Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York.
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis.
Zitieren
APA
Spyropoulos, A. C., & Vedantham, S. (2026). Advanced Therapy for Intermediate-Risk Pulmonary Embolism. New England Journal of Medicine, 394(20), 2052-2054. https://doi.org/10.1056/nejme2603115
Vancouver
Spyropoulos AC, Vedantham S. Advanced Therapy for Intermediate-Risk Pulmonary Embolism. New England Journal of Medicine. 2026;394(20):2052-2054. doi:10.1056/nejme2603115
BibTeX
@article{Spyropoulos2026,
author = {Spyropoulos, Alex C and Vedantham, Suresh},
title = {Advanced Therapy for Intermediate-Risk Pulmonary Embolism},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {20},
pages = {2052--2054},
doi = {10.1056/nejme2603115}
}
EUVIMED